We would like to extend our warmest thanks to Stacy Hurt 🌻, Chief Patient Officer of Parexel, for presenting to our eClinical team this morning and lighting up our minds - and hearts - with your story and vision for operationalized patient-first clinical research. At eClinical our mission to help bring new treatments to patients faster has always been our reason for helping biopharma more easily manage the data of clinical trials. As a team we aim to frequently remind ourselves of this "why." When the day-to-day gets busy and the work is deep in tech and data, this mission is the touchstone. However nothing calls us back to this "why" more than what happened today - a direct connection to the patient experience from someone who has been there, is there, and is passionately advocating for trial design and execution that reduces patient burden and improves the experience. Thank you, Stacy, for your openness and critical reminders. The more we collectively understand the lived experience of the people waiting for life-changing therapies, the more we can actively consider our individual role in this mission - and impact change.
Thank you eClinical Solutions Raj Indupuri Vidhi Goel for inviting me to speak - it demonstrates how much you care about patients ❤️ We had a GREAT discussion- so wonderful for your team to open up and share! This type of honest dialogue bodes positive change
Wonderful presentation today!
Innovative Leadership in Life Sciences & Technology Talent Solutions: Founder & CEO of Recruits Lab & BioJobs Lab, Driving Organizational Success through Cutting-Edge Recruitment Strategies
1moWhat a touching and inspiring session, eClinical Solutions! Stacy Hurt's insights as Chief Patient Officer of Parexel must have been truly enlightening, emphasizing the importance of patient-centered clinical research. It's heartening to see your commitment to enhancing trial management and data handling to accelerate new treatments. Here's to continuing to prioritize patient experience and advancing impactful therapies.